THE STUDY ON HbA1c AND FENOFIBRATE ON THE HDL OF THE PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE-II-Reference-Cited by-同舟云学术

THE STUDY ON HbA1c AND FENOFIBRATE ON THE HDL OF THE PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE-II

Published:2021-06-01 Issue: Volume: Page:77-79
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Anand Piyush¹,Ahmed Iftekher²,Prasad Raj Ranjan³,Jana Debarshi⁴

Affiliation:

1. Tutor, Department of Pharmacology, Jawaharlal Nehru Medical College, Bhagalpur

2. Professor and HOD, Department of Pharmacology, Jawaharlal Nehru Medical College, Bhagalpur

3. Prof and Head, Department of Pharmacology, Darbhanga Medical College, Laheriasarai.

4. Young Scientist, IPGMER and SSKM Hospital, Kolkata.

Abstract

Introduction: Diabetes mellitus (DM) is a prevalent non communicable disease. Aims & objectives: Aim of the present study is to evaluate the efcacy of Omega-3 Fatty acids and Fenobrate in the treatment of dyslipidemia in the patients of Type-II Diabetes Mellitus with an objective to provide guidelines for better treatment of dyslipidemia in patients with Type-II Diabetes Mellitus. Material and method: Estimation of HbAlc was be done before starting therapy and thereafter every 12 weeks upto 24 weeks. the Department of Pharmacology, Darbhanga Medical College, Laheriasaria, with all facilities such as was furnished laboratory, necessary equipments and infrastructure. Conclusion: Fenobrate effectively controlled the total cholesterol and TG levels, increased the HDLcholesterol level, especially in its small fraction, and improved vascular function of patients with type 2 diabe

Publisher

World Wide Journals

Reference10 articles.

1. Powers AC. In: Harrison's Principles of Internal Medicine. 18th ed. Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J, editors. New York: McGraw Hill; 2012. pp. 2968–3003. [Google Scholar]

2. Madhu SV. In: RSSDI Textbook of Diabetes Mellitus. 3rd ed. Chandalia HB, Sridar GR, Das AK, Madhu SV, Mohan V, Rao PV, editors. New Delhi: Jaypee The Health Sciences Publishers Ltd; 2014. pp. 773–86.

3. Maitra A. In: Robbins and Cotran Pathologic Basis of Disease. 8th ed. Kumar V, Abbas KA, Fausta N, Aster CJ, editors. Philadelphia: Elsevier Inc; 2010. pp. 1130–48. [Google Scholar]

4. Risérus U, Arnlöv J, Brismar K, Zethelius B, Berglund L, Vessby B, et al. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004;27:2041–6.

5. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.